Tender Details

Country: USA
Summary: Completion of Pharmacokinetics for the Mad Portion of the Rr-Hnk Phase 1 Study
UST Ref No: 79739147
Deadline: 13 Mar 2023
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: NCATS-23-002383
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Center for Advancing Translational Sciences (NCATS) intends to negotiate on a sole source basis with Labcorp Early Development Laboratories Inc for the Completion of Pharmacokinetics for the MAD Portion of the RR-HNK Phase 1 Study.
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE and SET ASIDE STATUS
The intended procurement is classified under NAICS code 541380 - Testing Laboratories with a Size Standard of $19 million.
REGULATORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures. Contracts awarded using FAR Part 13—Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6—Competition Requirements. FAR Subpart 13.106-1 (b) Soliciting from a single source provides that: For purchases not exceeding the simplified acquisition threshold, Contracting officers may solicit from one source IF the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name OR industrial mobilization).
The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2023-01 dated December 30, 2022.
DESCRIPTION OF REQUIREMENT
PURPOSE AND OBJECTIVES:
The National Center for Advancing Translational Sciences (NCATS) is currently developing a novel chemical entity for the treatment of depression. The lead compound has undergone extensive preclinical toxicology, demonstrating its excellent safety profile. In addition, its excellent antidepressant efficacy has been demonstrated in several animal models of depression. In alignment with the NCATS- goals to advance tran...
Documents:

23-002383_NOTICE-OF-INTENT-to-Sole-Source.pdf

If you are registered member, kindly login to view full details of this tender notice:

Completion of Pharmacokinetics for the Mad Portion of the Rr-Hnk Phase 1 Study - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Completion of Pharmacokinetics for the Mad Portion of the Rr-Hnk Phase 1 Study. This tender is published on USARFP under UST Ref No: 79739147 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-03-13.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.